Efficacy of standard vs extended therapy with peginterferon alfa-2b + ribavirin in patients with hepatitis C and HIV co-infection.
Phase of Trial: Phase III
Latest Information Update: 02 Mar 2011
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 02 Mar 2011 Results presented at the 18th Conference on Retroviruses and Opportunistic Infections.
- 05 Nov 2010 New trial record.